Evolving concepts in biofilm infections

Luanne Hall-Stoodley1, Paul Stoodley

  • 1Center for Genomic Sciences, Allegheny-Singer Research Institute, Pittsburgh, PA 15212, USA. lstoodle@wpahs.org

Cellular Microbiology
|April 21, 2009
PubMed

Insights

Pathogenic biofilms, microbial communities in chronic infections, are key survival strategies. This review explores in vivo biofilm phenotypes, challenges, and implications for understanding persistent diseases.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Medical Science

Background:

  • Biofilm formation is a critical survival strategy for numerous pathogens linked to chronic infections like cystic fibrosis pneumonia, otitis media, rhinosinusitis, and urinary tract infections.
  • Biofilms are surface-associated microbial communities encased in an extracellular polymeric substance (EPS) matrix, contributing to resistance against host immune responses and antibiotic treatments.
  • Despite their prevalence in chronic diseases, in vivo biofilm development outside of dental plaques remains under-investigated.

Purpose of the Study:

  • To review recent efforts in examining the biofilm phenotype in vivo.
  • To discuss the challenges associated with defining and identifying biofilms in clinical settings.
  • To explore the implications of in vivo biofilm characterization for understanding persistent microbial infections.

Main Methods:

  • Literature review of recent studies investigating in vivo biofilm phenotypes.
  • Analysis of challenges in defining and detecting biofilms in clinical samples.
  • Discussion of the significance of in vivo biofilm research.

Main Results:

  • Biofilm formation is a common characteristic of pathogens involved in persistent, treatment-resistant chronic infections.
  • In vivo studies face significant challenges in accurately defining and visualizing the biofilm phenotype.
  • Understanding in vivo biofilms is crucial for developing effective therapeutic strategies against chronic infections.

Conclusions:

  • Biofilms are crucial for pathogen persistence in chronic diseases, conferring resistance to therapies.
  • Defining the in vivo biofilm phenotype presents considerable methodological and interpretational challenges.
  • Further research into in vivo biofilms is essential for advancing treatment paradigms for chronic infectious diseases.